DK3150222T3 - Stabile immunogene sammensætninger af staphylococcus aureus-antigener - Google Patents
Stabile immunogene sammensætninger af staphylococcus aureus-antigener Download PDFInfo
- Publication number
- DK3150222T3 DK3150222T3 DK16193095.3T DK16193095T DK3150222T3 DK 3150222 T3 DK3150222 T3 DK 3150222T3 DK 16193095 T DK16193095 T DK 16193095T DK 3150222 T3 DK3150222 T3 DK 3150222T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigenes
- staphylococcus aureus
- immunogenic compositions
- stable immunogenic
- stable
- Prior art date
Links
- 241000191967 Staphylococcus aureus Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426476P | 2010-12-22 | 2010-12-22 | |
| EP11804822.2A EP2654784B1 (en) | 2010-12-22 | 2011-12-21 | Stable immunogenic compositions of staphylococcus aureus antigens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3150222T3 true DK3150222T3 (da) | 2020-01-27 |
Family
ID=45444677
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16193095.3T DK3150222T3 (da) | 2010-12-22 | 2011-12-21 | Stabile immunogene sammensætninger af staphylococcus aureus-antigener |
| DK11804822.2T DK2654784T3 (en) | 2010-12-22 | 2011-12-21 | STABLE IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENES |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11804822.2T DK2654784T3 (en) | 2010-12-22 | 2011-12-21 | STABLE IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENES |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20130259896A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2654784B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6097478B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR101808398B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103826656B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011346535B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013016153A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2819120C (cg-RX-API-DMAC7.html) |
| DK (2) | DK3150222T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2769425T3 (cg-RX-API-DMAC7.html) |
| HU (2) | HUE033072T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL226793B (cg-RX-API-DMAC7.html) |
| MX (1) | MX350170B (cg-RX-API-DMAC7.html) |
| PL (2) | PL2654784T3 (cg-RX-API-DMAC7.html) |
| PT (2) | PT3150222T (cg-RX-API-DMAC7.html) |
| RU (1) | RU2570730C2 (cg-RX-API-DMAC7.html) |
| SI (2) | SI2654784T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012085872A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2893938B1 (en) | 2004-09-22 | 2019-03-06 | GlaxoSmithKline Biologicals SA | Immunogenic composition for use in vaccination against Staphylococcei |
| PE20110023A1 (es) | 2009-06-22 | 2011-01-31 | Wyeth Llc | Composiciones inmunogenicas de antigenos de staphylococcus aureus |
| EP3461496B1 (en) | 2009-06-22 | 2023-08-23 | Wyeth LLC | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
| MX2012013664A (es) * | 2010-06-04 | 2013-01-24 | Wyeth Llc | Formulaciones de vacuna. |
| AU2012266880A1 (en) * | 2011-03-16 | 2013-10-03 | Regents Of The University Of Minnesota | Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus |
| GB201310008D0 (en) * | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
| JP2016540764A (ja) * | 2013-12-04 | 2016-12-28 | グリコヴァキシン アーゲー | 大腸菌で合成された糖タンパク質ワクチンによる黄色ブドウ球菌感染の予防 |
| IL310015B1 (en) * | 2013-12-31 | 2025-10-01 | Access To Advanced Health Inst | Single vial formulation |
| US20170100476A1 (en) * | 2014-04-10 | 2017-04-13 | Asit Biotech S.A. | Hsp-free allergen preparation |
| KR20200040812A (ko) * | 2017-08-16 | 2020-04-20 | 머크 샤프 앤드 돔 코포레이션 | 폐렴구균 접합체 백신 제제 |
| GB201802339D0 (en) | 2018-02-13 | 2018-03-28 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| KR102649069B1 (ko) | 2018-05-31 | 2024-03-19 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물 |
| CN112261871B (zh) | 2018-07-28 | 2022-05-17 | 韩国外泌体生技有限公司 | 用于使外排体冻干的方法 |
| KR102163806B1 (ko) | 2018-07-30 | 2020-10-07 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물 |
| US20230151102A1 (en) * | 2020-01-13 | 2023-05-18 | Aptevo Research And Development Llc | Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| EP0138854B1 (en) | 1983-03-08 | 1992-11-04 | Chiron Mimotopes Pty. Ltd. | Antigenically active amino acid sequences |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
| US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6008341A (en) | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
| BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
| WO1997014800A1 (en) | 1995-10-16 | 1997-04-24 | Smithkline Beecham Plc | Novel saliva binding protein |
| GB9622159D0 (en) | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
| GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| AU1537699A (en) | 1997-11-26 | 1999-06-15 | Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency | Extracellular matrix-binding proteins from (staphylococcus aureus) |
| US6680195B1 (en) | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| MXPA01002119A (es) * | 1998-08-31 | 2003-03-27 | Inhibitex Inc | Vacunas multicomponentes. |
| US6936258B1 (en) | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
| US7115730B1 (en) | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
| US7384640B1 (en) | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
| BRPI0111639B8 (pt) | 2000-06-08 | 2021-05-25 | Intercell Ag | uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica. |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| JP2004535187A (ja) | 2001-06-07 | 2004-11-25 | ワイス・ホールデイングス・コーポレーシヨン | アジュバントとしてのコレラホロトキシンの突然変異形 |
| WO2002098369A2 (en) | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
| EP2339344A1 (en) | 2001-06-15 | 2011-06-29 | Inhibitex, Inc. | Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| NZ561879A (en) | 2003-03-07 | 2009-05-31 | Wyeth Corp | Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| US20060251675A1 (en) | 2003-03-17 | 2006-11-09 | Michael Hagen | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| EP2893938B1 (en) * | 2004-09-22 | 2019-03-06 | GlaxoSmithKline Biologicals SA | Immunogenic composition for use in vaccination against Staphylococcei |
| EP2476433A1 (en) * | 2006-03-30 | 2012-07-18 | GlaxoSmithKline Biologicals S.A. | Immunogenic composition |
| AR060188A1 (es) * | 2006-03-30 | 2008-05-28 | Glaxosmithkline Biolog Sa | Procedimiento de conjugacion |
| GB0606416D0 (en) * | 2006-03-30 | 2006-05-10 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| WO2007127668A2 (en) | 2006-04-26 | 2007-11-08 | Wyeth | Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations |
| EP2086581B1 (en) * | 2006-11-07 | 2014-08-13 | Sanofi Pasteur Biologics, LLC | Stabilization of vaccines by lyophilization |
| ES2615390T3 (es) | 2008-03-05 | 2017-06-06 | Sanofi Pasteur | Proceso para estabilizar una composición de vacuna que contiene adyuvante |
| PE20110023A1 (es) * | 2009-06-22 | 2011-01-31 | Wyeth Llc | Composiciones inmunogenicas de antigenos de staphylococcus aureus |
-
2011
- 2011-12-21 WO PCT/IB2011/055883 patent/WO2012085872A2/en not_active Ceased
- 2011-12-21 HU HUE11804822A patent/HUE033072T2/hu unknown
- 2011-12-21 US US13/993,887 patent/US20130259896A1/en not_active Abandoned
- 2011-12-21 DK DK16193095.3T patent/DK3150222T3/da active
- 2011-12-21 PL PL11804822T patent/PL2654784T3/pl unknown
- 2011-12-21 SI SI201131064A patent/SI2654784T1/sl unknown
- 2011-12-21 KR KR1020157031951A patent/KR101808398B1/ko not_active Expired - Fee Related
- 2011-12-21 EP EP11804822.2A patent/EP2654784B1/en active Active
- 2011-12-21 PT PT161930953T patent/PT3150222T/pt unknown
- 2011-12-21 EP EP16193095.3A patent/EP3150222B1/en active Active
- 2011-12-21 PL PL16193095T patent/PL3150222T3/pl unknown
- 2011-12-21 AU AU2011346535A patent/AU2011346535B2/en not_active Ceased
- 2011-12-21 MX MX2013006960A patent/MX350170B/es active IP Right Grant
- 2011-12-21 PT PT118048222T patent/PT2654784T/pt unknown
- 2011-12-21 CA CA2819120A patent/CA2819120C/en active Active
- 2011-12-21 SI SI201131825T patent/SI3150222T1/sl unknown
- 2011-12-21 DK DK11804822.2T patent/DK2654784T3/en active
- 2011-12-21 BR BR112013016153A patent/BR112013016153A2/pt not_active Application Discontinuation
- 2011-12-21 ES ES16193095T patent/ES2769425T3/es active Active
- 2011-12-21 ES ES11804822.2T patent/ES2614815T3/es active Active
- 2011-12-21 HU HUE16193095A patent/HUE047263T2/hu unknown
- 2011-12-21 RU RU2013128277/15A patent/RU2570730C2/ru active IP Right Revival
- 2011-12-21 CN CN201180068105.5A patent/CN103826656B/zh not_active Expired - Fee Related
- 2011-12-21 KR KR1020137018851A patent/KR20130114210A/ko not_active Ceased
- 2011-12-22 JP JP2011280781A patent/JP6097478B2/ja not_active Expired - Fee Related
-
2013
- 2013-06-06 IL IL226793A patent/IL226793B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3150222T3 (da) | Stabile immunogene sammensætninger af staphylococcus aureus-antigener | |
| DK2892550T3 (da) | Stabile vandige formuleringer af adalimumab | |
| DK2567524T3 (da) | Reduktion af protokolspild | |
| DK2603232T3 (da) | Stabile formuleringer af linaclotid | |
| DK2528602T4 (da) | Formuleringer af bendamustin | |
| DK3156056T3 (da) | Farmaceutiske sammensætninger der består af sorbitanestere | |
| EP2549993A4 (en) | ANTIMICROBIAL COMPOSITIONS | |
| DK2571517T4 (da) | Langtidsvirkende formuleringer af insuliner | |
| EP2941128C0 (en) | ANTIMICROBIAL COMPOSITIONS | |
| DK3725778T3 (da) | Formuleringer af enzalutamid | |
| DK3336097T3 (da) | Fremstilling af ikke-krystallinsk obeticholsyre | |
| DK3520805T3 (da) | Sammensætninger til behandling af myelofibrose | |
| EP2736491A4 (en) | BEPOTASTIN COMPOSITION | |
| DK2872152T3 (da) | Acellulære pro-tolerogene sammensætninger til behandling/forebyggelse af transplantatafstødning | |
| DK3831406T3 (da) | Stabile formuleringer af Neisseria-Meningitidis-RLP2086-antigener | |
| EP2709972A4 (en) | NON-FLAMMABLE COMPOSITIONS FROM CHLORINE TRIFLUORPROPES | |
| EP2725900A4 (en) | ANTIMICROBIAL COMPOSITION | |
| DK2822568T3 (da) | Anvendelser af caseinsammensætninger | |
| EP2870200A4 (en) | HARDENABLE ANTIMICROBIAL COMPOSITION | |
| CO6930368A2 (es) | Composiciones de yodo-povidona estable | |
| DK2633006T3 (da) | Fremstilling af fornybart bio-destillat | |
| DK3106150T3 (da) | Forbedrede farmaceutiske sammensætninger af pimobendan | |
| DK3577176T3 (da) | Lavtemperatur hærdelige klæbemiddelssammensætninger | |
| EP2934121A4 (en) | IMPROVED ANTIMICROBIAL COMPOSITIONS | |
| DK3409686T3 (da) | Sammensætning omfattende en blanding af cd95-fc-isoformer |